MCNAY JOSEPH C 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Oct 20, 2017
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Exercise of In-Money
Common Stock
2017-10-19$0.15/sh+66,667$10,000→ 1,823,602 total - Conversion
Common Stock
2017-10-19$0.15/sh+417,824$62,674→ 1,756,935 total - Exercise of In-Money
Common Stock Warrant (right to buy)
2017-10-19−66,667→ 0 totalExercise: $0.15From: 2013-04-19Exp: 2017-10-19→ Common Stock (66,667 underlying) - Conversion
Convertible Promissory Note (right to buy)
2017-10-19−417,824→ 0 totalExercise: $0.15From: 2012-10-19Exp: 2017-10-19→ Common Stock (417,824 underlying)
Footnotes (1)
- [F1]The Convertible Promissory Note in the principal amount of $50,000 accrued $12,673.65 in interest and both principal and interest were converted into 417,824 shares of common stock at a conversion price of $0.15 per share.